Khoso Baluch's Net Worth
$266 Thousand
Who is Khoso Baluch?
Khoso Baluch does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CorMedix Inc., Processa Pharmaceuticals, Inc., and Longeveron Inc..
SEC CIK
Khoso Baluch's CIK is 0001686223
Past Insider Trading and Trends
2016 was Khoso Baluch's most active year for acquiring shares with 7 total transactions. Khoso Baluch's most active month to acquire stocks was the month of September. 2023 was Khoso Baluch's most active year for disposing of shares, totalling 1 transactions. Khoso Baluch's most active month to dispose stocks was the month of May. 2020 saw Khoso Baluch paying a total of $595,666.99 for 108,960 shares, this is the most they've acquired in one year. In 2024 Khoso Baluch cashed out on 125 shares for a total of $132.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CorMedix Inc. (CRMD) Snapshot price: $5.67
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +8.61% | 4.83K |
$4.14 | $19,985.09 | 60.91K |
Aug 13
| |||
Form 4
| +6.66% | 3.5K |
$2.61 | $9,135.00 | 56.08K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
| +4.99% | 2.5K |
$7.55 | $18,875.00 | 52.58K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +5.50% | 25K |
$1.25 | $30,495.00 | 479.25K |
Nov 26 - Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +85.94% | 104.17K |
$0.48 | $49,999.68 | 225.37K |
Dec 12
| |||
Form 4
| +42.60% | 36.21K |
$0.42 | $15,025.91 | 121.21K |
Aug 18
| |||
Form 4
| +750.00% | 75K |
$0.48 | $35,625.00 | 85K |
May 17
| |||
Form 4
|
∞
| 10K |
$1.77 | $17,700.00 | 10K |
Dec 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Processa Pharmaceuticals, Inc. (PCSA) Snapshot price: $1.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 4
| +123.64% | 15.46K |
—
|
—
| 27.95K |
Jun 27
| |||
Form 4
|
∞
| 12.5K |
$0.80 | $10,000.00 | 12.5K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Longeveron Inc. (LGVN) Snapshot price: $1.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +157.98% | 23.5K |
—
|
—
| 38.38K |
Aug 15
| |||
Form 4
| -0.83% | -125.00 |
$1.06 | -$132.50 | 14.88K |
Jun 9
| |||
Form 4
| +200.00% | 10K |
$1.43 | $14,256.59 | 15K |
Dec 28 - Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |